Nike Faces Increasing Competition From Adidas, Under Armour

Nike Faces Increasing Competition From Adidas, Under Armour

Nike is facing increasing competition from adidas and Under Armour and may project a slowdown in goods to be delivered to retailers in its earnings next week, according to Canaccord Genuity. “Our concerns on NKE are mounting,” consumer analyst Camilo Lyon said in a note on Friday. “Our retailing checks coupled with discussions with our industry contacts point to adidas and UA continuing to gain share at NKE’s expense.” Nike, […]

Read More ˃
Royal Bank Scotland Slips More Than 1%

Royal Bank Scotland Slips More Than 1%

Royal Bank Scotland slips more than 1% after Reuters reports the company has begun winding down its global shipping finance business, ending efforts to sell it off during a worsening downturn across the freight industry. Shipping industry sources have told Reuters that RBS had been trying to sell its Greek shipping business, valued at around $3 billion, for more than a year. A source close to RBS told Reuters the […]

Read More ˃
HD Supply Holdings Prices Incremental Term Loan

HD Supply Holdings Prices Incremental Term Loan

HD Supply Holdings said Monday it has commitments from investors to fund a new tranche of term loans in an aggregate principal amount of $550 million priced at 99.50% of the principal amount and bearing interest at a rate of LIBOR plus 2.75% per annum. The rate will be reduced to a rate of LIBOR plus 2.50% per annum upon the company reaching a total consolidated leverage ratio of 3.0x […]

Read More ˃
Xencor Shares Touch New Record

Xencor Shares Touch New Record

Xencor shares rose to a new record on Thursday after the biopharmaceutical company said it has begun dosing patients in the latest phase of a trial of subcutaneously administered XmAb7195, a potential treatment for allergic disease. XNCR was up nearly 4% at $24.21 recently, having earlier traded as high as $24.55. The 52-week low is at $9.89. Complete data results from an earlier phase of the trial showed that XmAb7195 […]

Read More ˃
Exelixis Shares Rise to 14-Year High

Exelixis Shares Rise to 14-Year High

Exelixis shares rose to their highest level since 2002 on Wednesday after the company said it received approval from the European Commission for Cabometyx tablets to treat advanced renal cell carcinoma in adults following prior vascular endothelial growth factor targeted therapy.  EXEL was over 5% higher at $13.03 recently, trading in a new 52-week range between $3.55 and $13.19. The approval is based on data from a phase 3 study […]

Read More ˃
Accenture Receives FedRAMP Certification

Accenture Receives FedRAMP Certification

Accenture, a provider of management consulting, technology and outsourcing services, said Tuesday that the U.S. Federal government has awarded Accenture Federal Services FedRAMP certification for the Accenture Federal Cloud ERP solution, determining that its enterprise resource planning solution is compliant with federal security requirements. FedRAMP, the Federal Risk and Authorization Management Program, is a government-wide program that provides a standardized approach for assessing, authorizing and continuously monitoring the security of […]

Read More ˃
Ford Motor Shelves Plans for New Compact Car Family for Emerging Markets

Ford Motor Shelves Plans for New Compact Car Family for Emerging Markets

Ford Motor Company is just firmer after Reuters reports the company has shelved plans to produce a new compact car family designed mainly for emerging markets like India and China, industry sources said, reflecting disappointing sales of mainstream models in the world’s fastest growing car markets. India and China were expected to be the main manufacturing hubs for the new B500 range, slated to begin production in 2018 and to […]

Read More ˃
Catalyst Pharma Jumps 12%

Catalyst Pharma Jumps 12%

Shares of Catalyst Pharmaceuticals were surging Friday morning after the biopharmaceutical firm said the Food and Drug Administration granted orphan drug status for Firdapse for the treatment of myasthenia gravis. Myasthenia gravis is a rase disease caused by antibodies to the muscle-specific kinase (MuSK-MG) and is estimated to affect approximately 4,500 patients in the U.S. The company said that many patients with MuSK-MG are currently treated with anticholinesterase inhibitors or […]

Read More ˃
Materion Gets Nadcap Merit Status For Lorain, Ohio Plant

Materion Gets Nadcap Merit Status For Lorain, Ohio Plant

Materion an advanced materials solutions provider, said it has earned Nadcap Merit Status from the Performance Review Institute for its Lorain, Ohio plant, for heat treatment and tensile and hardness testing. The company said that Nadcap accreditation is often required for companies producing material or providing services to the aerospace and defense industries. Materion has held Nadcap accreditation since 2009. Having demonstrated ongoing commitment to quality by satisfying customer requirements […]

Read More ˃
T-Mobile US Suspends Sales of Samsung Galaxy Note7

T-Mobile US Suspends Sales of Samsung Galaxy Note7

T-Mobile US  said it has suspended the sale of the Samsung Galaxy Note7 devices across all of its channels after Samsung said it was stopping sales globally. “We will work closely with Samsung to ensure T-Mobile customers who have already purchased the device are well taken care of,” it said. Samsung has recalled all Galaxy Note 7 smartphones due to a battery cell issue, with the devices catching fire. The […]

Read More ˃